Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Charles G. Longen
Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer
Cancer Research
Cancer Research
Oncology
Related publications
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Clinical Cancer Research
Cancer Research
Oncology
Flightless I Homolog Represses Prostate Cancer Progression Through Targeting Androgen Receptor Signaling
Clinical Cancer Research
Cancer Research
Oncology
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
Cancer Research
Cancer Research
Oncology
Aberrant Activation of Androgen Receptor in a New Neuropeptide-Autocrine Model of Androgen-Insensitive Prostate Cancer
Cancer Research
Cancer Research
Oncology
Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Collateral Resistance to Taxanes in Enzalutamide-Resistant Prostate Cancer Through Aberrant Androgen Receptor and Its Variants
Cancer Science
Cancer Research
Medicine
Oncology
Heat Shock Protein 70 Inhibitors Suppress Androgen Receptor Expression in LNCaP95 Prostate Cancer Cells
Cancer Science
Cancer Research
Medicine
Oncology
Prostate Cancer Characteristics Associated With Response to Pre-Receptor Targeting of the Androgen Axis
PLoS ONE
Multidisciplinary
Looking Beyond Androgen Receptor Signaling in the Treatment of Advanced Prostate Cancer
Advances in Andrology